Trial Profile
Enhanced Identification of Very Early Response to Seroquel XR Added to an Antidepressant for the Treatment of Major Depressive Disorder With or Without Generalized Anxiety Disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2011
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Antidepressants
- Indications Generalised anxiety disorder; Major depressive disorder
- Focus Therapeutic Use
- 21 Jan 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 21 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.